Skip to content

Comparative study of moderate sedation and deep sedation in upper gastrointestinal endoscopy

Comparative study of moderate sedation and deep sedation in upper gastrointestinal endoscopy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038050
Enrollment
Unknown
Registered
2020-09-09
Start date
2020-09-01
Completion date
Unknown
Last updated
2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the upper digestive tract requiring endoscopy

Interventions

Moderate sandation:Midazolam combined with fentanyl
Deep sedation:Midazolam combined with fentanyl

Sponsors

Shangluo Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years, regardless of gender; 2. The American society of anesthesiologists (ASA) I - II level; 3. Patients with indications and selected EGD in our hospital; 4. Subjects participate voluntarily and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications of routine endoscopic operations or patients who refused to be sedate; 2. Patients with uncontrolled circulatory and respiratory diseases that may threaten their lives, such as uncontrolled severe hypertension, severe arrhythmia, unstable angina, acute respiratory infection and asthma attack period; 3. Patients with other severe cardiopulmonary diseases; 4. Patients with liver dysfunction (child-Pugh grade C or above), acute upper gastrointestinal bleeding with shock, severe anemia, gastrointestinal obstruction with gastric content retention; 5. Risk of allergy to sedatives and analgesics and other severe anesthesia; 6. Addicts of long-term use of sedative and analgesic drugs or alcohol or sedative and analgesic drugs; 7. Pregnant and lactating women; 8. Without escort or guardian; 9. Other conditions in which the researcher considers it inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
Depth of sedation;Hemodynamics and oxygen metabolism;Adverse events;

Secondary

MeasureTime frame
Sedation time;

Countries

China

Contacts

Public ContactLiu Xiao

Shangluo Central Hospital

liux0108@163.com+86 18591093080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026